These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18667508)

  • 1. Herpes simplex virus downregulates secretory leukocyte protease inhibitor: a novel immune evasion mechanism.
    Fakioglu E; Wilson SS; Mesquita PM; Hazrati E; Cheshenko N; Blaho JA; Herold BC
    J Virol; 2008 Oct; 82(19):9337-44. PubMed ID: 18667508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection.
    Skeate JG; Porras TB; Woodham AW; Jang JK; Taylor JR; Brand HE; Kelly TJ; Jung JU; Da Silva DM; Yuan W; Martin Kast W
    J Gen Virol; 2016 Feb; 97(2):422-434. PubMed ID: 26555393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
    Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
    Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory leukocyte protease inhibitor inhibits expression of polymeric immunoglobulin receptor via the NF-κB signaling pathway.
    Mikami Y; Iwase T; Komiyama Y; Matsumoto N; Oki H; Komiyama K
    Mol Immunol; 2015 Oct; 67(2 Pt B):568-74. PubMed ID: 26239418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.
    Jana NK; Gray LR; Shugars DC
    J Virol; 2005 May; 79(10):6432-40. PubMed ID: 15858026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital herpes simplex virus type 2 infection in humanized HIV-transgenic mice triggers HIV shedding and is associated with greater neurological disease.
    Nixon B; Fakioglu E; Stefanidou M; Wang Y; Dutta M; Goldstein H; Herold BC
    J Infect Dis; 2014 Feb; 209(4):510-22. PubMed ID: 23990571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines.
    Svensson D; Aidoukovitch A; Anders E; Jönsson D; Nebel D; Nilsson BO
    Inflamm Res; 2017 Sep; 66(9):823-831. PubMed ID: 28597116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory Leukocyte Protease Inhibitor (SLPI) in mucosal tissues: Protects against inflammation, but promotes cancer.
    Nugteren S; Samsom JN
    Cytokine Growth Factor Rev; 2021 Jun; 59():22-35. PubMed ID: 33602652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Abrogates NF-κB Activation in DNA Sensing Signal Pathway.
    Ye R; Su C; Xu H; Zheng C
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous secretory leukocyte protease inhibitor inhibits microbial-induced monocyte activation.
    Nugteren S; Simons-Oosterhuis Y; Menckeberg CL; Hulleman-van Haaften DH; Lindenbergh-Kortleve DJ; Samsom JN
    Eur J Immunol; 2023 Feb; 53(2):e2249964. PubMed ID: 36480463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.
    Antoniades CG; Khamri W; Abeles RD; Taams LS; Triantafyllou E; Possamai LA; Bernsmeier C; Mitry RR; O'Brien A; Gilroy D; Goldin R; Heneghan M; Heaton N; Jassem W; Bernal W; Vergani D; Ma Y; Quaglia A; Wendon J; Thursz M
    Hepatology; 2014 Apr; 59(4):1564-76. PubMed ID: 24282114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity.
    Jiang Z; Su C; Zheng C
    J Virol; 2016 Dec; 90(24):11056-11061. PubMed ID: 27681138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation.
    Klimenkova O; Ellerbeck W; Klimiankou M; Ünalan M; Kandabarau S; Gigina A; Hussein K; Zeidler C; Welte K; Skokowa J
    Blood; 2014 Feb; 123(8):1239-49. PubMed ID: 24352879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin inhibits in vitro herpes simplex virus type 1 and 2 infection by modulating cellular NF-κB and MAPK pathways.
    Chu Y; Lv X; Zhang L; Fu X; Song S; Su A; Chen D; Xu L; Wang Y; Wu Z; Yun Z
    BMC Microbiol; 2020 Jul; 20(1):227. PubMed ID: 32723300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of herpesvirus-induced HIV-1 replication by cyclopentenone prostaglandins: role of IkappaB kinase (IKK).
    Amici C; Belardo G; Rozera C; Bernasconi D; Santoro MG
    AIDS; 2004 Jun; 18(9):1271-80. PubMed ID: 15362659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus 2 (HSV-2) prevents dendritic cell maturation, induces apoptosis, and triggers release of proinflammatory cytokines: potential links to HSV-HIV synergy.
    Stefanidou M; Ramos I; Mas Casullo V; Trépanier JB; Rosenbaum S; Fernandez-Sesma A; Herold BC
    J Virol; 2013 Feb; 87(3):1443-53. PubMed ID: 23152529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells.
    Halford WP; Kemp CD; Isler JA; Davido DJ; Schaffer PA
    J Virol; 2001 Jul; 75(13):6143-53. PubMed ID: 11390616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription.
    McNeely TB; Shugars DC; Rosendahl M; Tucker C; Eisenberg SP; Wahl SM
    Blood; 1997 Aug; 90(3):1141-9. PubMed ID: 9242546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal Progranulin expression is induced by H. pylori, but independent of Secretory Leukocyte Protease Inhibitor (SLPI) expression.
    Wex T; Kuester D; Schönberg C; Schindele D; Treiber G; Malfertheiner P
    BMC Gastroenterol; 2011 May; 11():63. PubMed ID: 21612671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.